nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0967	0.14	CbGbCtD
Salmeterol—CYP3A7—Paclitaxel—ovarian cancer	0.0967	0.14	CbGbCtD
Salmeterol—CYP3A5—Paclitaxel—ovarian cancer	0.0725	0.105	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0699	0.101	CbGbCtD
Salmeterol—CYP3A7—Docetaxel—ovarian cancer	0.0699	0.101	CbGbCtD
Salmeterol—CYP2C8—Paclitaxel—ovarian cancer	0.0697	0.101	CbGbCtD
Salmeterol—CYP3A4—Topotecan—ovarian cancer	0.0571	0.0829	CbGbCtD
Salmeterol—CYP3A5—Docetaxel—ovarian cancer	0.0524	0.0761	CbGbCtD
Salmeterol—CYP3A4—Vinorelbine—ovarian cancer	0.0402	0.0584	CbGbCtD
Salmeterol—CYP3A4—Paclitaxel—ovarian cancer	0.0283	0.041	CbGbCtD
Salmeterol—CYP3A4—Docetaxel—ovarian cancer	0.0204	0.0297	CbGbCtD
Salmeterol—CYP3A4—Doxorubicin—ovarian cancer	0.0152	0.0221	CbGbCtD
Salmeterol—Body temperature increased—Vinorelbine—ovarian cancer	0.000411	0.00132	CcSEcCtD
Salmeterol—Abdominal pain—Vinorelbine—ovarian cancer	0.000411	0.00132	CcSEcCtD
Salmeterol—Connective tissue disorder—Docetaxel—ovarian cancer	0.00041	0.00132	CcSEcCtD
Salmeterol—Diarrhoea—Melphalan—ovarian cancer	0.000407	0.00131	CcSEcCtD
Salmeterol—Pain in extremity—Epirubicin—ovarian cancer	0.000407	0.00131	CcSEcCtD
Salmeterol—Nausea—Chlorambucil—ovarian cancer	0.000406	0.0013	CcSEcCtD
Salmeterol—Dizziness—Topotecan—ovarian cancer	0.000402	0.00129	CcSEcCtD
Salmeterol—Tremor—Paclitaxel—ovarian cancer	0.000402	0.00129	CcSEcCtD
Salmeterol—Migraine—Epirubicin—ovarian cancer	0.0004	0.00129	CcSEcCtD
Salmeterol—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000398	0.00128	CcSEcCtD
Salmeterol—Agitation—Paclitaxel—ovarian cancer	0.000394	0.00127	CcSEcCtD
Salmeterol—Angioedema—Paclitaxel—ovarian cancer	0.000392	0.00126	CcSEcCtD
Salmeterol—Cardiac disorder—Docetaxel—ovarian cancer	0.000387	0.00125	CcSEcCtD
Salmeterol—Vomiting—Topotecan—ovarian cancer	0.000386	0.00124	CcSEcCtD
Salmeterol—Malaise—Paclitaxel—ovarian cancer	0.000386	0.00124	CcSEcCtD
Salmeterol—Rash—Topotecan—ovarian cancer	0.000383	0.00123	CcSEcCtD
Salmeterol—Hypersensitivity—Vinorelbine—ovarian cancer	0.000383	0.00123	CcSEcCtD
Salmeterol—Dermatitis—Topotecan—ovarian cancer	0.000383	0.00123	CcSEcCtD
Salmeterol—Headache—Topotecan—ovarian cancer	0.000381	0.00123	CcSEcCtD
Salmeterol—Palpitations—Paclitaxel—ovarian cancer	0.000379	0.00122	CcSEcCtD
Salmeterol—Vomiting—Melphalan—ovarian cancer	0.000378	0.00122	CcSEcCtD
Salmeterol—Immune system disorder—Docetaxel—ovarian cancer	0.000377	0.00121	CcSEcCtD
Salmeterol—Pain in extremity—Doxorubicin—ovarian cancer	0.000376	0.00121	CcSEcCtD
Salmeterol—Mediastinal disorder—Docetaxel—ovarian cancer	0.000376	0.00121	CcSEcCtD
Salmeterol—Rash—Melphalan—ovarian cancer	0.000375	0.00121	CcSEcCtD
Salmeterol—Dermatitis—Melphalan—ovarian cancer	0.000375	0.00121	CcSEcCtD
Salmeterol—Cough—Paclitaxel—ovarian cancer	0.000374	0.0012	CcSEcCtD
Salmeterol—Asthenia—Vinorelbine—ovarian cancer	0.000373	0.0012	CcSEcCtD
Salmeterol—Arrhythmia—Docetaxel—ovarian cancer	0.000373	0.0012	CcSEcCtD
Salmeterol—Abdominal pain upper—Epirubicin—ovarian cancer	0.000372	0.0012	CcSEcCtD
Salmeterol—Migraine—Doxorubicin—ovarian cancer	0.000371	0.00119	CcSEcCtD
Salmeterol—Hypertension—Paclitaxel—ovarian cancer	0.00037	0.00119	CcSEcCtD
Salmeterol—Mental disorder—Docetaxel—ovarian cancer	0.000366	0.00118	CcSEcCtD
Salmeterol—Arthralgia—Paclitaxel—ovarian cancer	0.000365	0.00117	CcSEcCtD
Salmeterol—Chest pain—Paclitaxel—ovarian cancer	0.000365	0.00117	CcSEcCtD
Salmeterol—Myalgia—Paclitaxel—ovarian cancer	0.000365	0.00117	CcSEcCtD
Salmeterol—Nasopharyngitis—Epirubicin—ovarian cancer	0.000364	0.00117	CcSEcCtD
Salmeterol—Anxiety—Paclitaxel—ovarian cancer	0.000364	0.00117	CcSEcCtD
Salmeterol—Malnutrition—Docetaxel—ovarian cancer	0.000363	0.00117	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000362	0.00117	CcSEcCtD
Salmeterol—Nausea—Topotecan—ovarian cancer	0.000361	0.00116	CcSEcCtD
Salmeterol—Discomfort—Paclitaxel—ovarian cancer	0.00036	0.00116	CcSEcCtD
Salmeterol—Dry mouth—Paclitaxel—ovarian cancer	0.000357	0.00115	CcSEcCtD
Salmeterol—Diarrhoea—Vinorelbine—ovarian cancer	0.000356	0.00114	CcSEcCtD
Salmeterol—Nausea—Melphalan—ovarian cancer	0.000354	0.00114	CcSEcCtD
Salmeterol—Asthma—Epirubicin—ovarian cancer	0.000352	0.00113	CcSEcCtD
Salmeterol—Influenza—Epirubicin—ovarian cancer	0.000352	0.00113	CcSEcCtD
Salmeterol—Back pain—Docetaxel—ovarian cancer	0.000351	0.00113	CcSEcCtD
Salmeterol—Oedema—Paclitaxel—ovarian cancer	0.00035	0.00113	CcSEcCtD
Salmeterol—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00035	0.00113	CcSEcCtD
Salmeterol—Muscle spasms—Docetaxel—ovarian cancer	0.000349	0.00112	CcSEcCtD
Salmeterol—Infection—Paclitaxel—ovarian cancer	0.000347	0.00112	CcSEcCtD
Salmeterol—Dizziness—Vinorelbine—ovarian cancer	0.000344	0.00111	CcSEcCtD
Salmeterol—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000344	0.00111	CcSEcCtD
Salmeterol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000343	0.0011	CcSEcCtD
Salmeterol—Tachycardia—Paclitaxel—ovarian cancer	0.000341	0.0011	CcSEcCtD
Salmeterol—Skin disorder—Paclitaxel—ovarian cancer	0.00034	0.00109	CcSEcCtD
Salmeterol—Bronchitis—Epirubicin—ovarian cancer	0.000338	0.00109	CcSEcCtD
Salmeterol—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000337	0.00108	CcSEcCtD
Salmeterol—Vomiting—Vinorelbine—ovarian cancer	0.000331	0.00106	CcSEcCtD
Salmeterol—Rash—Vinorelbine—ovarian cancer	0.000328	0.00105	CcSEcCtD
Salmeterol—Dermatitis—Vinorelbine—ovarian cancer	0.000328	0.00105	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000327	0.00105	CcSEcCtD
Salmeterol—Headache—Vinorelbine—ovarian cancer	0.000326	0.00105	CcSEcCtD
Salmeterol—Asthma—Doxorubicin—ovarian cancer	0.000325	0.00105	CcSEcCtD
Salmeterol—Influenza—Doxorubicin—ovarian cancer	0.000325	0.00105	CcSEcCtD
Salmeterol—Palpitations—Docetaxel—ovarian cancer	0.000321	0.00103	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000319	0.00103	CcSEcCtD
Salmeterol—Hyperglycaemia—Epirubicin—ovarian cancer	0.000317	0.00102	CcSEcCtD
Salmeterol—Cough—Docetaxel—ovarian cancer	0.000317	0.00102	CcSEcCtD
Salmeterol—Insomnia—Paclitaxel—ovarian cancer	0.000316	0.00102	CcSEcCtD
Salmeterol—Pneumonia—Epirubicin—ovarian cancer	0.000315	0.00101	CcSEcCtD
Salmeterol—Paraesthesia—Paclitaxel—ovarian cancer	0.000314	0.00101	CcSEcCtD
Salmeterol—Hypertension—Docetaxel—ovarian cancer	0.000314	0.00101	CcSEcCtD
Salmeterol—Infestation NOS—Epirubicin—ovarian cancer	0.000314	0.00101	CcSEcCtD
Salmeterol—Infestation—Epirubicin—ovarian cancer	0.000314	0.00101	CcSEcCtD
Salmeterol—Bronchitis—Doxorubicin—ovarian cancer	0.000313	0.00101	CcSEcCtD
Salmeterol—Dyspnoea—Paclitaxel—ovarian cancer	0.000312	0.001	CcSEcCtD
Salmeterol—Myalgia—Docetaxel—ovarian cancer	0.000309	0.000995	CcSEcCtD
Salmeterol—Arthralgia—Docetaxel—ovarian cancer	0.000309	0.000995	CcSEcCtD
Salmeterol—Chest pain—Docetaxel—ovarian cancer	0.000309	0.000995	CcSEcCtD
Salmeterol—Nausea—Vinorelbine—ovarian cancer	0.000309	0.000994	CcSEcCtD
Salmeterol—Dyspepsia—Paclitaxel—ovarian cancer	0.000308	0.00099	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000307	0.000988	CcSEcCtD
Salmeterol—Conjunctivitis—Epirubicin—ovarian cancer	0.000305	0.00098	CcSEcCtD
Salmeterol—Urinary tract infection—Epirubicin—ovarian cancer	0.000305	0.00098	CcSEcCtD
Salmeterol—Dry mouth—Docetaxel—ovarian cancer	0.000302	0.000973	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000302	0.000973	CcSEcCtD
Salmeterol—Fatigue—Paclitaxel—ovarian cancer	0.000302	0.00097	CcSEcCtD
Salmeterol—Pain—Paclitaxel—ovarian cancer	0.000299	0.000962	CcSEcCtD
Salmeterol—Constipation—Paclitaxel—ovarian cancer	0.000299	0.000962	CcSEcCtD
Salmeterol—Anaphylactic shock—Docetaxel—ovarian cancer	0.000296	0.000954	CcSEcCtD
Salmeterol—Oedema—Docetaxel—ovarian cancer	0.000296	0.000954	CcSEcCtD
Salmeterol—Epistaxis—Epirubicin—ovarian cancer	0.000296	0.000951	CcSEcCtD
Salmeterol—Infection—Docetaxel—ovarian cancer	0.000295	0.000947	CcSEcCtD
Salmeterol—Sinusitis—Epirubicin—ovarian cancer	0.000294	0.000946	CcSEcCtD
Salmeterol—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000293	0.000944	CcSEcCtD
Salmeterol—Pneumonia—Doxorubicin—ovarian cancer	0.000292	0.000939	CcSEcCtD
Salmeterol—Nervous system disorder—Docetaxel—ovarian cancer	0.000291	0.000935	CcSEcCtD
Salmeterol—Infestation—Doxorubicin—ovarian cancer	0.00029	0.000933	CcSEcCtD
Salmeterol—Infestation NOS—Doxorubicin—ovarian cancer	0.00029	0.000933	CcSEcCtD
Salmeterol—Tachycardia—Docetaxel—ovarian cancer	0.000289	0.000931	CcSEcCtD
Salmeterol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000288	0.000927	CcSEcCtD
Salmeterol—Skin disorder—Docetaxel—ovarian cancer	0.000288	0.000926	CcSEcCtD
Salmeterol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000286	0.00092	CcSEcCtD
Salmeterol—Rhinitis—Epirubicin—ovarian cancer	0.000282	0.000908	CcSEcCtD
Salmeterol—Conjunctivitis—Doxorubicin—ovarian cancer	0.000282	0.000907	CcSEcCtD
Salmeterol—Urinary tract infection—Doxorubicin—ovarian cancer	0.000282	0.000907	CcSEcCtD
Salmeterol—Pharyngitis—Epirubicin—ovarian cancer	0.000279	0.000899	CcSEcCtD
Salmeterol—Urticaria—Paclitaxel—ovarian cancer	0.000278	0.000894	CcSEcCtD
Salmeterol—Connective tissue disorder—Epirubicin—ovarian cancer	0.000277	0.00089	CcSEcCtD
Salmeterol—Abdominal pain—Paclitaxel—ovarian cancer	0.000276	0.000889	CcSEcCtD
Salmeterol—Body temperature increased—Paclitaxel—ovarian cancer	0.000276	0.000889	CcSEcCtD
Salmeterol—Epistaxis—Doxorubicin—ovarian cancer	0.000274	0.00088	CcSEcCtD
Salmeterol—Sinusitis—Doxorubicin—ovarian cancer	0.000272	0.000876	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00027	0.000869	CcSEcCtD
Salmeterol—Insomnia—Docetaxel—ovarian cancer	0.000268	0.000863	CcSEcCtD
Salmeterol—Paraesthesia—Docetaxel—ovarian cancer	0.000266	0.000856	CcSEcCtD
Salmeterol—Dyspnoea—Docetaxel—ovarian cancer	0.000264	0.00085	CcSEcCtD
Salmeterol—Cardiac disorder—Epirubicin—ovarian cancer	0.000261	0.00084	CcSEcCtD
Salmeterol—Rhinitis—Doxorubicin—ovarian cancer	0.000261	0.00084	CcSEcCtD
Salmeterol—Dyspepsia—Docetaxel—ovarian cancer	0.000261	0.00084	CcSEcCtD
Salmeterol—Pharyngitis—Doxorubicin—ovarian cancer	0.000258	0.000831	CcSEcCtD
Salmeterol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000258	0.000829	CcSEcCtD
Salmeterol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000256	0.000823	CcSEcCtD
Salmeterol—Fatigue—Docetaxel—ovarian cancer	0.000256	0.000822	CcSEcCtD
Salmeterol—Immune system disorder—Epirubicin—ovarian cancer	0.000254	0.000818	CcSEcCtD
Salmeterol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000254	0.000816	CcSEcCtD
Salmeterol—Pain—Docetaxel—ovarian cancer	0.000254	0.000816	CcSEcCtD
Salmeterol—Constipation—Docetaxel—ovarian cancer	0.000254	0.000816	CcSEcCtD
Salmeterol—Arrhythmia—Epirubicin—ovarian cancer	0.000251	0.000809	CcSEcCtD
Salmeterol—Asthenia—Paclitaxel—ovarian cancer	0.000251	0.000807	CcSEcCtD
Salmeterol—Mental disorder—Epirubicin—ovarian cancer	0.000247	0.000793	CcSEcCtD
Salmeterol—Malnutrition—Epirubicin—ovarian cancer	0.000245	0.000788	CcSEcCtD
Salmeterol—Feeling abnormal—Docetaxel—ovarian cancer	0.000244	0.000786	CcSEcCtD
Salmeterol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000242	0.00078	CcSEcCtD
Salmeterol—Cardiac disorder—Doxorubicin—ovarian cancer	0.000242	0.000778	CcSEcCtD
Salmeterol—Tension—Epirubicin—ovarian cancer	0.00024	0.000773	CcSEcCtD
Salmeterol—Diarrhoea—Paclitaxel—ovarian cancer	0.000239	0.00077	CcSEcCtD
Salmeterol—Nervousness—Epirubicin—ovarian cancer	0.000238	0.000766	CcSEcCtD
Salmeterol—Back pain—Epirubicin—ovarian cancer	0.000237	0.000762	CcSEcCtD
Salmeterol—Muscle spasms—Epirubicin—ovarian cancer	0.000236	0.000758	CcSEcCtD
Salmeterol—Immune system disorder—Doxorubicin—ovarian cancer	0.000235	0.000757	CcSEcCtD
Salmeterol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000235	0.000755	CcSEcCtD
Salmeterol—Abdominal pain—Docetaxel—ovarian cancer	0.000234	0.000754	CcSEcCtD
Salmeterol—Body temperature increased—Docetaxel—ovarian cancer	0.000234	0.000754	CcSEcCtD
Salmeterol—Arrhythmia—Doxorubicin—ovarian cancer	0.000233	0.000748	CcSEcCtD
Salmeterol—Dizziness—Paclitaxel—ovarian cancer	0.000231	0.000744	CcSEcCtD
Salmeterol—Mental disorder—Doxorubicin—ovarian cancer	0.000228	0.000734	CcSEcCtD
Salmeterol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000227	0.000731	CcSEcCtD
Salmeterol—Malnutrition—Doxorubicin—ovarian cancer	0.000227	0.000729	CcSEcCtD
Salmeterol—Agitation—Epirubicin—ovarian cancer	0.000225	0.000724	CcSEcCtD
Salmeterol—Tension—Doxorubicin—ovarian cancer	0.000222	0.000716	CcSEcCtD
Salmeterol—Vomiting—Paclitaxel—ovarian cancer	0.000222	0.000715	CcSEcCtD
Salmeterol—Malaise—Epirubicin—ovarian cancer	0.000221	0.000711	CcSEcCtD
Salmeterol—Rash—Paclitaxel—ovarian cancer	0.000221	0.000709	CcSEcCtD
Salmeterol—Dermatitis—Paclitaxel—ovarian cancer	0.00022	0.000709	CcSEcCtD
Salmeterol—Nervousness—Doxorubicin—ovarian cancer	0.00022	0.000708	CcSEcCtD
Salmeterol—Back pain—Doxorubicin—ovarian cancer	0.000219	0.000705	CcSEcCtD
Salmeterol—Headache—Paclitaxel—ovarian cancer	0.000219	0.000705	CcSEcCtD
Salmeterol—Hypersensitivity—Docetaxel—ovarian cancer	0.000218	0.000703	CcSEcCtD
Salmeterol—Muscle spasms—Doxorubicin—ovarian cancer	0.000218	0.000701	CcSEcCtD
Salmeterol—Palpitations—Epirubicin—ovarian cancer	0.000217	0.000697	CcSEcCtD
Salmeterol—Cough—Epirubicin—ovarian cancer	0.000214	0.000688	CcSEcCtD
Salmeterol—Asthenia—Docetaxel—ovarian cancer	0.000213	0.000684	CcSEcCtD
Salmeterol—Hypertension—Epirubicin—ovarian cancer	0.000212	0.00068	CcSEcCtD
Salmeterol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00021	0.000677	CcSEcCtD
Salmeterol—Myalgia—Epirubicin—ovarian cancer	0.000209	0.000671	CcSEcCtD
Salmeterol—Arthralgia—Epirubicin—ovarian cancer	0.000209	0.000671	CcSEcCtD
Salmeterol—Chest pain—Epirubicin—ovarian cancer	0.000209	0.000671	CcSEcCtD
Salmeterol—Agitation—Doxorubicin—ovarian cancer	0.000208	0.00067	CcSEcCtD
Salmeterol—Anxiety—Epirubicin—ovarian cancer	0.000208	0.000669	CcSEcCtD
Salmeterol—Nausea—Paclitaxel—ovarian cancer	0.000208	0.000668	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000207	0.000666	CcSEcCtD
Salmeterol—Discomfort—Epirubicin—ovarian cancer	0.000206	0.000663	CcSEcCtD
Salmeterol—Malaise—Doxorubicin—ovarian cancer	0.000204	0.000658	CcSEcCtD
Salmeterol—Dry mouth—Epirubicin—ovarian cancer	0.000204	0.000656	CcSEcCtD
Salmeterol—Diarrhoea—Docetaxel—ovarian cancer	0.000203	0.000653	CcSEcCtD
Salmeterol—Palpitations—Doxorubicin—ovarian cancer	0.0002	0.000644	CcSEcCtD
Salmeterol—Oedema—Epirubicin—ovarian cancer	0.0002	0.000643	CcSEcCtD
Salmeterol—Anaphylactic shock—Epirubicin—ovarian cancer	0.0002	0.000643	CcSEcCtD
Salmeterol—Infection—Epirubicin—ovarian cancer	0.000199	0.000639	CcSEcCtD
Salmeterol—Cough—Doxorubicin—ovarian cancer	0.000198	0.000636	CcSEcCtD
Salmeterol—Nervous system disorder—Epirubicin—ovarian cancer	0.000196	0.000631	CcSEcCtD
Salmeterol—Dizziness—Docetaxel—ovarian cancer	0.000196	0.000631	CcSEcCtD
Salmeterol—Hypertension—Doxorubicin—ovarian cancer	0.000196	0.00063	CcSEcCtD
Salmeterol—Tachycardia—Epirubicin—ovarian cancer	0.000195	0.000628	CcSEcCtD
Salmeterol—Skin disorder—Epirubicin—ovarian cancer	0.000194	0.000625	CcSEcCtD
Salmeterol—Myalgia—Doxorubicin—ovarian cancer	0.000193	0.000621	CcSEcCtD
Salmeterol—Arthralgia—Doxorubicin—ovarian cancer	0.000193	0.000621	CcSEcCtD
Salmeterol—Chest pain—Doxorubicin—ovarian cancer	0.000193	0.000621	CcSEcCtD
Salmeterol—Anxiety—Doxorubicin—ovarian cancer	0.000192	0.000619	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000192	0.000617	CcSEcCtD
Salmeterol—Discomfort—Doxorubicin—ovarian cancer	0.000191	0.000613	CcSEcCtD
Salmeterol—Dry mouth—Doxorubicin—ovarian cancer	0.000189	0.000607	CcSEcCtD
Salmeterol—Vomiting—Docetaxel—ovarian cancer	0.000188	0.000606	CcSEcCtD
Salmeterol—Rash—Docetaxel—ovarian cancer	0.000187	0.000601	CcSEcCtD
Salmeterol—Dermatitis—Docetaxel—ovarian cancer	0.000187	0.000601	CcSEcCtD
Salmeterol—Headache—Docetaxel—ovarian cancer	0.000186	0.000597	CcSEcCtD
Salmeterol—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000185	0.000595	CcSEcCtD
Salmeterol—Oedema—Doxorubicin—ovarian cancer	0.000185	0.000595	CcSEcCtD
Salmeterol—Infection—Doxorubicin—ovarian cancer	0.000184	0.000591	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000182	0.000586	CcSEcCtD
Salmeterol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000181	0.000584	CcSEcCtD
Salmeterol—Insomnia—Epirubicin—ovarian cancer	0.000181	0.000582	CcSEcCtD
Salmeterol—Tachycardia—Doxorubicin—ovarian cancer	0.000181	0.000581	CcSEcCtD
Salmeterol—Skin disorder—Doxorubicin—ovarian cancer	0.00018	0.000578	CcSEcCtD
Salmeterol—Paraesthesia—Epirubicin—ovarian cancer	0.00018	0.000578	CcSEcCtD
Salmeterol—Dyspnoea—Epirubicin—ovarian cancer	0.000178	0.000574	CcSEcCtD
Salmeterol—Nausea—Docetaxel—ovarian cancer	0.000176	0.000566	CcSEcCtD
Salmeterol—Dyspepsia—Epirubicin—ovarian cancer	0.000176	0.000566	CcSEcCtD
Salmeterol—Fatigue—Epirubicin—ovarian cancer	0.000172	0.000555	CcSEcCtD
Salmeterol—Pain—Epirubicin—ovarian cancer	0.000171	0.00055	CcSEcCtD
Salmeterol—Constipation—Epirubicin—ovarian cancer	0.000171	0.00055	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000169	0.000542	CcSEcCtD
Salmeterol—Insomnia—Doxorubicin—ovarian cancer	0.000167	0.000538	CcSEcCtD
Salmeterol—Paraesthesia—Doxorubicin—ovarian cancer	0.000166	0.000534	CcSEcCtD
Salmeterol—Dyspnoea—Doxorubicin—ovarian cancer	0.000165	0.000531	CcSEcCtD
Salmeterol—Feeling abnormal—Epirubicin—ovarian cancer	0.000165	0.00053	CcSEcCtD
Salmeterol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000164	0.000526	CcSEcCtD
Salmeterol—Dyspepsia—Doxorubicin—ovarian cancer	0.000163	0.000524	CcSEcCtD
Salmeterol—Fatigue—Doxorubicin—ovarian cancer	0.00016	0.000513	CcSEcCtD
Salmeterol—Urticaria—Epirubicin—ovarian cancer	0.000159	0.000511	CcSEcCtD
Salmeterol—Pain—Doxorubicin—ovarian cancer	0.000158	0.000509	CcSEcCtD
Salmeterol—Constipation—Doxorubicin—ovarian cancer	0.000158	0.000509	CcSEcCtD
Salmeterol—Abdominal pain—Epirubicin—ovarian cancer	0.000158	0.000509	CcSEcCtD
Salmeterol—Body temperature increased—Epirubicin—ovarian cancer	0.000158	0.000509	CcSEcCtD
Salmeterol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000152	0.00049	CcSEcCtD
Salmeterol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000151	0.000487	CcSEcCtD
Salmeterol—Hypersensitivity—Epirubicin—ovarian cancer	0.000147	0.000474	CcSEcCtD
Salmeterol—Urticaria—Doxorubicin—ovarian cancer	0.000147	0.000473	CcSEcCtD
Salmeterol—Abdominal pain—Doxorubicin—ovarian cancer	0.000146	0.000471	CcSEcCtD
Salmeterol—Body temperature increased—Doxorubicin—ovarian cancer	0.000146	0.000471	CcSEcCtD
Salmeterol—Asthenia—Epirubicin—ovarian cancer	0.000143	0.000462	CcSEcCtD
Salmeterol—Diarrhoea—Epirubicin—ovarian cancer	0.000137	0.00044	CcSEcCtD
Salmeterol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000136	0.000439	CcSEcCtD
Salmeterol—Asthenia—Doxorubicin—ovarian cancer	0.000133	0.000427	CcSEcCtD
Salmeterol—Dizziness—Epirubicin—ovarian cancer	0.000132	0.000425	CcSEcCtD
Salmeterol—Vomiting—Epirubicin—ovarian cancer	0.000127	0.000409	CcSEcCtD
Salmeterol—Diarrhoea—Doxorubicin—ovarian cancer	0.000127	0.000407	CcSEcCtD
Salmeterol—Rash—Epirubicin—ovarian cancer	0.000126	0.000406	CcSEcCtD
Salmeterol—Dermatitis—Epirubicin—ovarian cancer	0.000126	0.000405	CcSEcCtD
Salmeterol—Headache—Epirubicin—ovarian cancer	0.000125	0.000403	CcSEcCtD
Salmeterol—Dizziness—Doxorubicin—ovarian cancer	0.000122	0.000394	CcSEcCtD
Salmeterol—Nausea—Epirubicin—ovarian cancer	0.000119	0.000382	CcSEcCtD
Salmeterol—Vomiting—Doxorubicin—ovarian cancer	0.000118	0.000378	CcSEcCtD
Salmeterol—Rash—Doxorubicin—ovarian cancer	0.000117	0.000375	CcSEcCtD
Salmeterol—Dermatitis—Doxorubicin—ovarian cancer	0.000117	0.000375	CcSEcCtD
Salmeterol—Headache—Doxorubicin—ovarian cancer	0.000116	0.000373	CcSEcCtD
Salmeterol—Nausea—Doxorubicin—ovarian cancer	0.00011	0.000354	CcSEcCtD
